Literature DB >> 32238339

Evaluating the Feasibility of Frequent Cognitive Assessment Using the Mezurio Smartphone App: Observational and Interview Study in Adults With Elevated Dementia Risk.

Claire Lancaster1, Ivan Koychev2, Jasmine Blane2, Amy Chinner2, Leona Wolters2, Chris Hinds1.   

Abstract

BACKGROUND: By enabling frequent, sensitive, and economic remote assessment, smartphones will facilitate the detection of early cognitive decline at scale. Previous studies have sustained participant engagement with remote cognitive assessment over a week; extending this to a period of 1 month clearly provides a greater opportunity for measurement. However, as study durations are increased, the need to understand how participant burden and scientific value might be optimally balanced also increases.
OBJECTIVE: This study explored the little but often approach to assessment employed by the Mezurio app when prompting participants to interact every day for over a month. Specifically, this study aimed to understand whether this extended duration of remote study is feasible, and which factors promote sustained participant engagement over such periods.
METHODS: A total of 35 adults (aged 40-59 years) with no diagnosis of cognitive impairment were prompted to interact with the Mezurio smartphone app platform for up to 36 days, completing short, daily episodic memory tasks in addition to optional executive function and language tests. A subset (n=20) of participants completed semistructured interviews focused on their experience of using the app.
RESULTS: Participants complied with 80% of the daily learning tasks scheduled for subsequent tests of episodic memory, with 88% of participants still actively engaged by the final task. A thematic analysis of the participants' experiences highlighted schedule flexibility, a clear user interface, and performance feedback as important considerations for engagement with remote digital assessment.
CONCLUSIONS: Despite the extended study duration, participants demonstrated high compliance with the schedule of daily learning tasks and were extremely positive about their experiences. Long durations of remote digital interaction are therefore definitely feasible but only when careful attention is paid to the design of the users' experience. ©Claire Lancaster, Ivan Koychev, Jasmine Blane, Amy Chinner, Leona Wolters, Chris Hinds. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 02.04.2020.

Entities:  

Keywords:  Alzheimer disease; cognition; early diagnosis; ecological momentary assessment; feasibility study; mhealth; mobile phone; smartphone; technology assessment

Mesh:

Year:  2020        PMID: 32238339      PMCID: PMC7163418          DOI: 10.2196/16142

Source DB:  PubMed          Journal:  JMIR Mhealth Uhealth        ISSN: 2291-5222            Impact factor:   4.773


  30 in total

1.  Mood, motivation, and misinformation: aging and affective state influences on memory.

Authors:  Thomas M Hess; Lauren E Popham; Lisa Emery; Tonya Elliott
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2011-11-08

2.  Measuring slips and lapses when they occur - ambulatory assessment in application to cognitive failures.

Authors:  Stefanie Lange; Heinz-Martin Süß
Journal:  Conscious Cogn       Date:  2013-12-31

3.  Regular cognitive self-monitoring in community-dwelling older adults using an internet-based tool.

Authors:  Elise G Valdes; Nasreen A Sadeq; Aryn L Harrison Bush; David Morgan; Ross Andel
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

4.  The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease.

Authors:  Craig W Ritchie; Karen Ritchie
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

5.  Mobile technologies in the early detection of cognitive decline.

Authors:  Michèle Allard; Mathilde Husky; Gwénaëlle Catheline; Amandine Pelletier; Bixente Dilharreguy; Hélène Amieva; Karine Pérès; Alexandra Foubert-Samier; Jean-François Dartigues; Joel Swendsen
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 6.  Mobile technology for mental health assessment.

Authors:  Patricia A Areàn; Kien Hoa Ly; Gerhard Andersson
Journal:  Dialogues Clin Neurosci       Date:  2016-06       Impact factor: 5.986

7.  Engaging older people in an internet platform for cardiovascular risk self-management: a qualitative study among Dutch HATICE participants.

Authors:  Tessa van Middelaar; Cathrien R L Beishuizen; Juliette Guillemont; Mariagnese Barbera; Edo Richard; Eric P Moll van Charante
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

8.  Cloudy with a Chance of Pain: Engagement and Subsequent Attrition of Daily Data Entry in a Smartphone Pilot Study Tracking Weather, Disease Severity, and Physical Activity in Patients With Rheumatoid Arthritis.

Authors:  Samuel Reade; Karen Spencer; Jamie C Sergeant; Matthew Sperrin; David M Schultz; John Ainsworth; Rashmi Lakshminarayana; Bruce Hellman; Ben James; John McBeth; Caroline Sanders; William G Dixon
Journal:  JMIR Mhealth Uhealth       Date:  2017-03-24       Impact factor: 4.773

9.  Digital biomarkers for Alzheimer's disease: the mobile/ wearable devices opportunity.

Authors:  Lampros C Kourtis; Oliver B Regele; Justin M Wright; Graham B Jones
Journal:  NPJ Digit Med       Date:  2019-02-21

10.  Virtual navigation tested on a mobile app is predictive of real-world wayfinding navigation performance.

Authors:  Antoine Coutrot; Sophie Schmidt; Lena Coutrot; Jessica Pittman; Lynn Hong; Jan M Wiener; Christoph Hölscher; Ruth C Dalton; Michael Hornberger; Hugo J Spiers
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

View more
  8 in total

1.  Examination of the reliability and feasibility of two smartphone applications to assess executive functioning in racially diverse older adults.

Authors:  Samantha E John; Sarah A Evans; Bona Kim; Petek Ozgul; David W Loring; Monica Parker; James J Lah; Allan I Levey; Felicia C Goldstein
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2021-08-12

2.  Feasibility and Psychometric Integrity of Mobile Phone-Based Intensive Measurement of Cognition in Older Adults.

Authors:  Paul W H Brewster; Jonathan Rush; Lana Ozen; Rebecca Vendittelli; Scott M Hofer
Journal:  Exp Aging Res       Date:  2021-03-01       Impact factor: 1.652

3.  Dementia care and COVID-19 pandemic: a necessary digital revolution.

Authors:  Luca Cuffaro; Francesco Di Lorenzo; Simona Bonavita; Gioacchino Tedeschi; Letizia Leocani; Luigi Lavorgna
Journal:  Neurol Sci       Date:  2020-06-17       Impact factor: 3.307

Review 4.  Secondary Prevention of Dementia: Combining Risk Factors and Scalable Screening Technology.

Authors:  Triin Ojakäär; Ivan Koychev
Journal:  Front Neurol       Date:  2021-11-15       Impact factor: 4.003

5.  Neuroscience from the comfort of your home: Repeated, self-administered wireless dry EEG measures brain function with high fidelity.

Authors:  Florentine M Barbey; Francesca R Farina; Alison R Buick; Lena Danyeli; John F Dyer; Md Nurul Islam; Marina Krylova; Brian Murphy; Hugh Nolan; Laura M Rueda-Delgado; Martin Walter; Robert Whelan
Journal:  Front Digit Health       Date:  2022-07-29

6.  Feasibility and validity of ecological momentary cognitive testing among older adults with mild cognitive impairment.

Authors:  Raeanne C Moore; Robert A Ackerman; Madisen T Russell; Laura M Campbell; Colin A Depp; Philip D Harvey; Amy E Pinkham
Journal:  Front Digit Health       Date:  2022-08-05

Review 7.  Current advances in digital cognitive assessment for preclinical Alzheimer's disease.

Authors:  Fredrik Öhman; Jason Hassenstab; David Berron; Michael Schöll; Kathryn V Papp
Journal:  Alzheimers Dement (Amst)       Date:  2021-07-20

8.  Dementias Platform UK Clinical Studies and Great Minds Register: protocol of a targeted brain health studies recontact database.

Authors:  Ivan Koychev; Simon Young; Heather Holve; Michael Ben Yehuda; John Gallacher
Journal:  BMJ Open       Date:  2020-11-27       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.